Stock ACCD ACCOLADE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Accolade, Inc.

Equities

ACCD

US00437E1029

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-15 pm EDT 		5-day change 1st Jan Change
7.36 USD 0.00% Intraday chart for Accolade, Inc. +3.37% -38.72%
Apr. 30 Wells Fargo Cuts Price Target on Accolade to $10 From $12, Maintains Equalweight Rating MT
Apr. 26 Morgan Stanley Trims Accolade's Price Target to $12 From $13, Maintains Equal Weight Rating MT

Business Summary

Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.

Number of employees: 2,400

Sales per Business

USD in Million2023Weight2024Weight Delta
Access Fees
72.5 %
284 78.2 % 300 72.5 % +5.75%
Utilization-based Fees
27.5 %
79 21.8 % 114 27.5 % +44.06%

Sales per region

USD in Million2023Weight2024Weight Delta
United States
100.0 %
363 100.0 % 414 100.0 % +14.09%

Managers

Managers TitleAgeSince
Rajeev Singh CEO
 Chief Executive Officer 56 15-09-30
Stephen Barnes DFI
 Director of Finance/CFO 53 15-01-31
Robert Cavanaugh PSD
 President 55 15-11-01
Drew Garner CTO
 Chief Tech/Sci/R&D Officer - 16-01-31
Kristen Bruzek COO
 Chief Operating Officer - 15-02-28
Connie Hwang CTO
 Chief Tech/Sci/R&D Officer - 23-09-17
Rich Eskew CMP
 Compliance Officer - 15-01-31
Michael Hilton BRD
 Director/Board Member 60 15-11-01
Todd Friedman IRC
 Investor Relations Contact - -
Kelsi Harris HRO
 Human Resources Officer - 17-03-31

Members of the board

Members of the board TitleAgeSince
Michael Hilton BRD
 Director/Board Member 60 15-11-01
Patricia Wadors BRD
 Director/Board Member 59 20-02-23
Dawn Lepore BRD
 Director/Board Member 70 19-05-31
Rajeev Singh CEO
 Chief Executive Officer 56 15-09-30
Jeffrey Jordan BRD
 Director/Board Member 65 16-06-30
Peter Klein BRD
 Director/Board Member 61 19-09-26
Cindy Kent BRD
 Director/Board Member 55 21-01-24
Jeff Brodsky BRD
 Director/Board Member 59 21-06-01
Elizabeth Nabel BRD
 Director/Board Member 72 21-06-01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 78,356,908 76,038,806 ( 97.04 %) 0 97.04 %

Shareholders

NameEquities%Valuation
Brown Investment Advisory & Trust Co.
7.552 %
5,845,934 7.552 % 54 M $
ARK Investment Management LLC
7.251 %
5,613,043 7.251 % 52 M $
Vanguard Fiduciary Trust Co.
6.980 %
5,403,256 6.980 % 50 M $
AH Capital Management LLC
6.974 %
5,398,708 6.974 % 50 M $
BlackRock Advisors LLC
6.938 %
5,370,353 6.938 % 49 M $
JPMorgan Investment Management, Inc.
6.887 %
5,331,319 6.887 % 49 M $
Bellevue Asset Management AG
5.823 %
4,507,404 5.823 % 41 M $
Rock Springs Capital Management LP
4.502 %
3,485,000 4.502 % 32 M $
Dimensional Fund Advisors LP
2.604 %
2,015,561 2.604 % 19 M $
Nikko Asset Management Americas, Inc.
2.193 %
1,697,560 2.193 % 16 M $

Company contact information

Accolade, Inc.

1201 3rd Avenue Suite 1700

98101, Seattle

+206-926-8100

http://www.accolade.com
address Accolade, Inc.(ACCD)

Sector

Healthcare
Healthcare Services
Healthcare Providers & Services
Healthcare Facilities & Services
Other Healthcare Facilities & Services

Sales per Business

Ratings for Accolade, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
7.36 USD
Average target price
13.07 USD
Spread / Average Target
+77.54%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
ACCOLADE, INC. Stock Accolade, Inc.
-38.72% 577M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+18.41% 83.94B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-29.08% 70.3B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+3.59% 27.46B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-7.08% 17.8B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+2.07% 17.46B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+0.93% 15.46B
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
+6.78% 13.49B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+8.40% 13.06B
NATERA, INC. Stock Natera, Inc.
+68.45% 12.96B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. ACCD Stock
  4. Company Accolade, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW